New Advances In The Treatment Of Depression

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorKohana, Ruth
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDepartment of pharmacology and pharmacotherapyhu_HU
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2019-10-01T12:27:51Z
dc.date.available2019-10-01T12:27:51Z
dc.date.created2019-03-27
dc.description.abstractDepression is a common condition worldwide. Primary care physicians detect less than half of the cases with depression among their patients. Although wide diversity of pharmacological agents were developed in the last 20 years, around 60% of patients will not react to the pharmacological therapy. The aim of this paper is to review novel treatment for depression including Vagus Nerve Stimulation, Vortioxetine, Ketamine, Transcranial Magnetic Stimulation, cannabis and phototherapy.hu_HU
dc.description.correctorLB
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent35hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/273896
dc.language.isoenhu_HU
dc.subjectdepressionhu_HU
dc.subject.dspacepharmacologyhu_HU
dc.titleNew Advances In The Treatment Of Depressionhu_HU
Fájlok